Advertisement · 728 × 90
#
Hashtag
#ABCardionostics
Advertisement · 728 × 90
Post image Post image

WP2 | Antibody fragment selection for atherosclerosis

Partners: UBx (Lead), MAbS, MUMC, IMGT
#Atherosclerosis #EUproject #ABCardionostics

1 0 0 0
Post image Post image

🚀 𝗪𝗼𝗿𝗸 𝗣𝗮𝗰𝗸𝗮𝗴𝗲 𝘀𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁: 𝗲𝘅𝗽𝗹𝗼𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗯𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗯𝗹𝗼𝗰𝗸𝘀 𝗼𝗳 𝗼𝘂𝗿 𝗽𝗿𝗼𝗷𝗲𝗰𝘁

#EICpathfinder #EUproject #ABCardionostics #CardiovascularResearch

0 0 0 0
Post image

Another partner contributing to ABCardionostics project: Bordeaux INP

They develop innovative purification methods for antibodies, ensuring quality for ABCardionostics imaging & therapy.
#BordeauxINP #ABCardionostics #EICPathfinder

1 0 0 0
Post image

Discover more: abcardionostics.eu/abcardionost...

#EUproject #EICPathfinder #ABCardionostics

1 0 0 0
Post image Post image Post image Post image

The ABCardionostics consortium gathered in Maastricht on 6-7 Ocotber for its General Assembly, hosted by MUMC+.
A great opportunity to align, share progress, and strengthen collaboration!
#ABCardionostics #EICPathfinder #EUproject

0 0 0 0
Post image

CNIC drives the imaging front of ABCardionostics, pioneering a multi-marker PET/MRI approach and antibody labelling for advanced cardiovascular diagnostics.

#CNIC #ABCardionostics #EICPathfinder #EUproject

1 0 0 0
Post image

@cnrs.fr’s BacFly lab powers ABCardionostics with advanced antibody engineering, creating innovative bispecific antibodies for next-gen cardiovascular therapies.
#CNRS #BacFly #ABCardionostics #EICPathfinder #EUproject

0 0 0 0
Post image

Toulouse Biotechnology Institute drives ABCardionostics with cutting-edge biochip technology for high-throughput antibody target discovery and validation.
@inrae-france.bsky.social @cnrs.fr
#CNRS #INSA #INRAE #TBI #ABCardionostics #EICPathfinder

0 0 0 0

🚀 New events added to the #ABCardionostics website!
📍 General Assembly in Maastricht (6-7 Oct, hosted by MUMC)
📍 Antibody Technologies & Therapeutics Conference, Prato (15-18 Sept 2025)

Check out the details here 👉 abcardionostics.eu/events/

0 0 0 0
Post image

@univbordeaux.bsky.social coordinates ABCardionostics, with its CRMSB lab bringing top-tier expertise in phage display and antibody discovery to revolutionise cardiovascular care.
More info about the project: abcardionostics.eu
#ABCardionostics #EICPathfinder #EUproject

1 0 1 0
Preview
Congrès NSFA 2025 - Nouvelle Société Francophone d'Athérosclérose | La Santé au Coeur de nos Artères Le 17e Congrès de la Société française d’Athérosclérose se déroulera du 22 au 24 juin 2022 au Centre de Congrès « Le Bellevue », place Bellevue à Biarritz.

🫀 Our coordinator team (CRMSB, @univbordeaux.bsky.social) attended the NSFA 2025 Congress in Biarritz (18-20 June)!
A rich scientific programme, perfectly aligned with our project’s focus.
To know more: www.nsfa.asso.fr/nsfa/
#ABCardionostics #NSFA2025 #CardiovascularResearch #HorizonEurope

1 0 0 0
Congrès de la section 28 du CNRS - Sciencesconf.org

@univbordeaux.bsky.social (CRMSB), our coordinator team, is attending the CNRS Section 28 Congress in Reims on 5–6 June 2025! @universitereims.bsky.social

To know more about the congress: congress28-2025.sciencesconf.org
#ABCardionostics #HorizonEurope #CNRS #EICPathfinder

3 1 0 0
abcardionostics

On #EuropeDay, we celebrate the power of collaboration across borders!
ABCardionostics unites 8 partners to revolutionize cardiovascular care through cutting-edge imaging & immunotherapy.
Together for healthier Europe 🤝
Discover more: abcardionostics.eu

#EICPathfinder #ABCardionostics

0 0 0 0
Post image

The ABCardionostics website is live!
We're tackling ASVD with biotech & imaging innovations.
🌐 abcardionostics.eu
#EUHealth #HorizonEU #EICPathfinder #ABCardionostics #CVD

0 0 0 0
Post image

On March 10th, the ABCardionostics consortium held its General Assembly meeting online! This important gathering brought together our partners to review progress, share results, and discuss the latest scientific and technical advancements.
#ABCardionostics #EICPathfinder

0 0 0 0
Post image

Cardiovascular diseases remain a leading global health challenge. Through biotechnology and advanced imaging, we are working to identify high-risk patients earlier and offer personalized therapies, paving the way for a new era in cardiovascular medicine.
#ABCardionostics #EICPathfinder

0 0 0 0